| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Liu,Yu-Fen | Chairman | 3.05% | JIA YING INVESTMENT LTD. |
| GO FAR INTERNATIONAL CO., LTD. | Director | 23.52% | |
| GO GIANT INTERNATIONAL CO., LTD. | Director | 3.48% | |
| Huang,Hua-Wei | Independent Director | 0.00% | |
| Zhang,Yong-Fu | Independent Director | 0.00% | |
| Zhang,Zhi | Independent Director | 0.00% | |
| Xu,Lv-Bing | Independent Director | 0.00% |
Change Company Name to DABOMB PROTEIN BIOTECH CORPORATION
2024/05/27
Change Company Name to DABON PROTEIN BIOTECHNOLOGY CO., LTD. (FORMER NAME: DABON PROTEIN CO., LTD.)
2023/10/11
Change Capital to 1,000,000,000
2023/08/15
Change Capital to 700,000,000
2021/09/29
Change Capital to 500,000,000
2020/06/18
Change Capital to 300,000,000
2014/04/21
下載完整報告查看完整數據
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating income | 68,597 | 337,824 | 384,413 |
| Operating cost | 53,555 | 269,098 | 337,985 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 15,042 | 68,726 | 46,428 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 15,042 | 68,726 | 46,428 |
| Operating expenses | 15,279 | 70,549 | 76,358 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | -237 | -1,823 | -29,930 |
| Non-operating income and expenses | 3,702 | 17,889 | -26,018 |
| Net profit (loss) before tax | 3,465 | 16,066 | -55,948 |
| Income tax expense (benefits) | 1,364 | 4,429 | 1,077 |
| Net profit (loss) of ongoing business for the current period | 2,101 | 11,637 | -57,025 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | 2,101 | 11,637 | -57,025 |
| Other comprehensive profit (loss), net | 4,184 | 6,822 | -3,856 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | 6,285 | 18,459 | -60,881 |
| Net profit (loss) attributable to owners of parent company | 2,101 | 11,637 | -57,025 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | - | - | - |
| Comprehensive profit (loss) attributable to owners of parent company | 6,285 | 18,459 | -60,881 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | - | - | - |
| Basic earnings per share (yuan) | 0 | 0 | -1 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | 8,124 | 47,554 | 6,506 |
| Net cash inflows (outflows) from investing activities | -11,244 | -31,477 | -31,892 |
| Net cash inflow (outflow) from financing activities | -9,055 | -139,750 | 208,855 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | -1,733 | -2,726 | 1,339 |
| Increase (decrease) in cash and cash equivalents in the current period | -13,908 | -126,399 | 184,808 |
| Beginning balance of cash and cash equivalents | 253,586 | 379,985 | 195,177 |
| Ending balance of cash and cash equivalents | 239,678 | 253,586 | 379,985 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Current asset | 615,352 | 654,163 | 778,834 |
| Non-current asset | 672,284 | 661,108 | 623,062 |
| Total asset | 1,287,636 | 1,315,271 | 1,401,896 |
| Current liability | 152,260 | 178,976 | 356,768 |
| Non-current liability | 39,820 | 46,983 | 87,065 |
| Total liability | 192,080 | 225,959 | 443,833 |
| share capital | 719,419 | 719,419 | 628,159 |
| Equity - secruity token | - | - | - |
| capital reserve | 355,249 | 355,249 | 344,460 |
| retained earning | 28,412 | 26,311 | 4,295 |
| Other equity | -7,524 | -11,667 | -18,851 |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | 1,095,556 | 1,089,312 | 958,063 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | - | - | - |
| Total Equity | 1,095,556 | 1,089,312 | 958,063 |
| Share capital awaiting retirement (unit: share) | 0 | 0 | 0 |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 15 | 16 | 16 |
